Search Results - "Vojnovič, Željko"

Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial by Tan, Antoinette R, Wright, Gail S, Thummala, Anu R, Danso, Michael A, Popovic, Lazar, Pluard, Timothy J, Han, Hyo S, Vojnović, Željko, Vasev, Nikola, Ma, Ling, Richards, Donald A, Wilks, Sharon T, Milenković, Dušan, Yang, Zhao, Antal, Joyce M, Morris, Shannon R, O'Shaughnessy, Joyce

“…Trilaciclib is an intravenous cell-cycle inhibitor that transiently maintains immune cells and haemopoietic stem and progenitor cells in G1 arrest. By…”
Get full text

Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II Study by Tan, Antoinette R, Wright, Gail S, Thummala, Anu R, Danso, Michael A, Popovic, Lazar, Pluard, Timothy J, Han, Hyo S, Vojnović, Željko, Vasev, Nikola, Ma, Ling, Richards, Donald A, Wilks, Sharon T, Milenković, Dušan, Xiao, Jie, Sorrentino, Jessica, Horton, Janet, O'Shaughnessy, Joyce

“…We report final antitumor efficacy results from a phase II study of trilaciclib, an intravenous cyclin-dependent kinase 4/6 (CDK4/6) inhibitor, administered…”
Get full text

SMJERNICE ZA PROVOĐENJE DIJAGNOSTIČKIH PRETRAGA PRIJE POČETKA LIJEČENJA ONKOLOŠKOG BOLESNIKA – KLINIČKE PREPORUKE HRVATSKOG DRUŠTVA ZA INTERNISTIČKU ONKOLOGIJU HLZ-a I. dio: tumori urogenitalnog sustava (rak bubrega, rak mokraćnog mjehura, rak prostate, rak testisa), tumori probavnog sustava (rak jednjaka, rak želuca, rak debelog i završnog crijeva, rak gušterače, rak žučnih vodova, hepatocelularni rak, neuroendokrine novotvorine) by Šeparović, Robert, Vazdar, Ljubica, Tečić Vuger, Ana, Pavlović, Mirjana, Gnjidić, Milena, Prejac, Juraj, Goršić, Irma, Trivanović, Dragan, Čonkaš, Mislav, Vojnović, Željko, Horvatić-Herceg, Gordana, Alduk, Ana Marija, Dedić Plavetić, Natalija, Vrbanec, Damir

“…Rak je drugi najvažniji uzrok smrti u našoj zemlji, odmah nakon bolesti srca i krvnih žila. S pretpostavkom porasta incidencije i smrtnosti od raka u idućim…”
Get full text

Abstract PD1-06: Trilaciclib improves overall survival when given with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: Final analysis of a randomized phase 2 trial by O'Shaughnessy, Joyce, Wright, Gail S, Thummala, Anu R, Danso, Michael A, Popovic, Lazar, Pluard, Timothy J, Han, Hyo S, Vojnović, Željko, Vasev, Nikola, Ma, Ling, Richards, Donald A, Wilks, Sharon T, Milenković, Dušan, Xiao, Jie, Sorrentino, Jessica A, Horton, Janet, Tan, Antoinette R

“…Background Trilaciclib is an intravenous (IV) cyclin-dependent kinase 4/6 (CDK4/6) inhibitor. Preliminary data showed that adding trilaciclib prior to…”
Get full text

Clinical guidelines for diagnosis, treatment and monitoring of patients with invasive breast cancer – Croatian Oncology Society (BC-3 COS) by Ingrid Belac Lovasić, Martina Bašić Koretić, Paula Podolski, Natalija Dedić Plavetić, Tajana Silovski, Stjepko Pleština, Marijana Jazvić, Željko Soldić, Robert Šeparović, Ana Tečić Vuger, Lidija Beketić Orešković, Ilijan Tomaš, Josipa Flam, Branka Petrić Miše, Marija Ban, Vesna Telesmanić Dobrić, Anuška Budisavljević, Josipa Jović Zlatović, Marijo Nalbani, Željko Vojnović, Zlatko Marušić, Snježana Tomić, Manuela Avirović, Bojan Štambuk, Danko Velimir Vrdoljak, Maja Prutki, Boris Brkljačić, Tade Tadić, Davor Mijatović, Zdenko Stanec, Ivan Milas, Eduard Vrdoljak

“…Breast cancer is the most common cancer in women, which can be diagnosed early through screening, early detection and through education. When diagnosed early,…”
Get full text

CANCER PATIENTS FOLLOW-UP – CROATIAN SOCIETY OF MEDICAL ONCOLOGY CLINICAL GUIDELINES Part II: renal cell cancer, urinary bladder cancer, prostate cancer, testicular cancer by Gnjidić, Milena, Vojnović, Željko, Čonkaš, Mislav, Čabo, Filip Grubišić, Belev, Borislav, Budisavljević, Anuška, Gilja, Ivan, Plavetić, Natalija Dedić, Šeparović, Robert, Vrbanec, Damir

“…The treatment of oncological patients must be based upon multidisciplinary approach, and takes place in specialized oncological centers. By the end of a…”
Get full text

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial by Iwata, Hiroji, Chia, Stephen K L, Bashford, Anna, Inoue, Kenichi, Armstrong, Anne C, Wong, Alvin, Buyse, Marc, Harvey, Vernon, Smith, John W., Konstantinovic, Zora Neskovic, Rodriguez, Gladys I., Jáñez Martinez, Noelia, Knoop, Ann Soegaard, De Boer, Richard Hendry, Rai, Yoshiaki, Yamamoto, Naohito, Brincat, Stephen, Papish, Steven William, Manalo, Yvonne, Sorensen, Peter Grundtvig, Aogi, Kenjiro, Shimizu, Satoru, Mainwaring, Paul, Chang, Jose, del Barco Berron, Sonia, Dickerson, Laura C., Klein, Leonard M., Ruxer, Robert, Veyret, Corinne, Wagnerova, Maria, Richards, Donald A., Vasileios, Asskikis, Dourthe, Louis Marie, Lu, Yen-Shen, Greenspan, Andrew R., Gonzalez Santiago, Santiago, Perren, Timothy John, Yau, Chung Cheung Thomas, Pikó, Béla, Sato, Nobuaki, Askoy, Sercan, Altundag, Mustafa Kadri, Saip, Pinar, Bajaj, Rajesh, Vestlev, Peter Michael, Dank, Magdolna, Cinieri, Saverio, Suszko-Kazarnowicz, Malgorzata, Yap, Yoon Sim, Chen, Shin-Cheh, Haley, Barbara Bacsik, Inhorn, Roger C., Koynova, Tatyana, Schneeweiss, Andreas, Cubedo Cervera, Ricardo, Urruticoechea Ribate, Ander, Schwartz, Garry H., Mocharnuk, Robert Scott, Alkhouri, Nabiel, Erickson, Nicholette, Traynor, Ann, Volterra, Fabio, Capo, Gerardo, Flaherty, Lawrence E., Baidas, Said, Lybaert, Willem, Holland, David R., Gonzalez Jimenez, Sonia, Vanlemmens, Laurence, Ruggeri, Enzo Maria, Desai, Ajit, Nixon, David Allen, O'Brien, Edward, Lanier, Keith S., Brescia, Frankie Ann, Richard, Vincent, Geldhof, Kurt, Bednarik, Otakar, Schwedler, Kathrin, Fries, Stefan, Klare, Peter, Griesinger, Frank, Trufflandier, Nathalie, Chetiyawardana, Anula D., Papandreou, Christos, Hornyak, Lajos, Simo, Erzsebet, Im, Seock-Ah, Ruit, Jan B., Ciltas, Aydin, Benekli, Mustafa, Conkright, William A., Ottaviano, Yvonne, Delmas, Andrew, Steele, Heather A., Bova, Abby R., Shirinian, Mihran, O'Rourke, Timothy J., Francisco, Michael, Carrillo Flores, Maria Regina

“…ExteNET showed that 1 year of neratinib, an irreversible pan-HER tyrosine kinase inhibitor, significantly improves 2-year invasive disease-free survival after…”
Get full text

Smjernice Hrvatskoga onkološkog društva za dijagnozu, liječenje i praćenje bolesnica/ka oboljelih od invazivnog raka dojke (HOD RD-3) by Belac Lovasić, Ingrid, Bašić Koretić, Martina, Podolski, Paula, Dedić Plavetić, Natalija, Silovski, Tajana, Pleština, Stjepko, Jazvić, Marijana, Soldić, Željko, Šeparović, Robert, Vuger, Ana Tečić, Beketić Orešković, Lidija, Tomaš, Ilijan, Flam, Josipa, Petrić Miše, Branka, Ban, Marija, Telesmanić-Dobrić, Vesna, Budisavljević, Anuška, Jović Zlatović, Josipa, Nalbani, Marijo, Vojnović, Željko, Marušić, Zlatko, Tomić, Snježana, Avirović, Manuela, Štambuk, Bojan, Vrdoljak, Danko Velimir, Prutki, Maja, Brkljačić, Boris, Tadić, Tade, Mijatović, Davor, Stanec, Zdenko, Milas, Ivan, Vrdoljak, Eduard

“…SAŽETAK Rak dojke je najčešći zloćudni tumor u žena koji se može probirom, redovitim kontrolama i zdravstvenim odgojem otkriti u ranim stadijima bolesti i…”
Get full text

Smjernice za dijagnosticiranje, liječenje i praćenje bolesnika s rakom mokraćnog mjehura by Jazvić, Marijana, Ružić, Boris, Krušlin, Božo, Šitum, Marijan, Pešutić Piasc, Valdi, Omrčen, Tomislav, Boraska Jelavić, Tihana, Gamulin, Marija, Alduk, Ana Marija, Čorić, Marijana, Murgić, Jure, Mažuran, Berislav, Šitum, Kristina, Drežnjak Madunić, Maja, Miletić, Damir, Vojnović, Željko

“…Rak mokraćnog mjehura (RMM) jest, u skladu s podatcima hrvatskog Registra za rak iz 2015. godine, drugi prema učestalosti tumor urinarnog sustava, odmah nakon…”
Get full text

Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical Trial by Vogelzang, Nicholas J, Beer, Tomasz M, Gerritsen, Winald, Oudard, Stéphane, Wiechno, Pawel, Kukielka-Budny, Bozena, Samal, Vladimir, Hajek, Jaroslav, Feyerabend, Susan, Khoo, Vincent, Stenzl, Arnulf, Csöszi, Tibor, Filipovic, Zoran, Goncalves, Frederico, Prokhorov, Alexander, Cheung, Eric, Hussain, Arif, Sousa, Nuno, Bahl, Amit, Hussain, Syed, Fricke, Harald, Kadlecova, Pavla, Scheiner, Tomas, Korolkiewicz, Roman P, Bartunkova, Jirina, Spisek, Radek

“…DCVAC/PCa is an active cellular immunotherapy designed to initiate an immune response against prostate cancer. To evaluate the efficacy and safety of DCVAC/PCa…”
Get more information

Impact of the coronavirus disease pandemic on cancer care in Croatia: a multicentre cross-sectional study by Kelemenic-Drazin, Renata, Budisavljevic, Anuska, Plavetic, Natalija Dedic, Fucak, Iva Kardum, Silovski, Tajana, Dobric, Vesna Telesmanic, Nalbani, Mario, Curic, Zvonimir, Boric-Mikez, Zvjezdana, Ladenhauser, Tatjana, Trivanovic, Dragan, Vojnovic, Zeljko, Tomas, Ilijan, Plestina, Stjepko

“…The coronavirus disease (COVID-19) pandemic has greatly affected the oncology community worldwide. Lockdowns, an epidemiological measure, have made it…”
Get full text

Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial by Maio, Michele, Lewis, Karl, Demidov, Lev, Bondarenko, Igor, Ascierto, Paolo A, Herbert, Christopher, Mackiewicz, Andrzej, Guminski, Alexander, Goodman, Grant R, Simmons, Brian, Ye, Chenglin, Cinat, Gabriela, Brown, Michael, Guminski, Alexander, Haydon, Andrew, Khattak, Adnan, McNeil, Catriona, Power, Jeremy, Roberts-Thomson, Rachel, Underhill, Craig, Berger, Thomas, Awada, Ahmad, Blockx, Nathalie, Buyse, Veronique, Mebis, Jeroen, Franke, Fábio André, Jobim de Azevedo, Sérgio, Silva Lazaretti, Nicolas, Mihalcioiu, Catalin, Petrella, Teresa, Song, Xinni, Wong, Ralph, Dabelic, Nina, Plestina, Stjepko, Vojnovic, Zeljko, Kocak, Ivo, Krajsova, Ivana, Kubala, Eugen, Melichar, Bohuslav, Dutriaux, Caroline, Joly, Pascal, Lacour, Jean-Philippe, Meyer, Nicolas, Mortier, Laurent, Fluck, Michael, Hassel, Jessica, Hauschild, Axel, Donnellan, Paul, McCaffrey, John, Power, Derek, Ariad, Samuel, Bar-Sela, Gil, Ron, Ilan, Schachter, Jacob, Berruti, Alfredo, Bianchi, Luca, Chiarion Sileni, Vanna, Cognetti, Francesco, Danielli, Riccardo, Di Giacomo, Anna Maria, Gianni, Luca, Goldhirsch, Aron, Guida, Michele, Maio, Michele, Mandalà, Mario, Marchetti, Paolo, Santoro, Armando, Kapiteijn, Ellen, Mackiewicz, Andrzej, Rutkowski, Piotr, Ferreira, Paula, Demidov, Lev, Gafton, Georgy, Makarova, Yulia, Jovanovic, Darjana, Kandolf Sekulovic, Lidija, Curiel Garcia, Maria Teresa, Majem Tarruella, Margarita, Marquez Rodas, Ivan, Puliats Rodriguez, Jose-M, Papworth, Karin, Bondarenko, Igor, Corrie, Pippa, Harries, Mark, Herbert, Christopher, Middleton, Mark, Patel, Poulam, Talbot, Toby, Agarwala, Sanjiv, Chapman, Paul, Conry, Robert, Doolittle, Gary, Gangadhar, Tara, Hallmeyer, Sigrun, Kass, Frederic, Lewis, Karl, Salama, April, Sikic, Branimir, Spigel, David, Whitman, Eric

“…Systemic adjuvant treatment might mitigate the high risk of disease recurrence in patients with resected stage IIC–III melanoma. The BRIM8 study evaluated…”
Get full text

Adjuvant vemurafenib in resected, BRAF V600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial by Maio, Michele, Lewis, Karl, Demidov, Lev, Mandalà, Mario, Bondarenko, Igor, Ascierto, Paolo A, Herbert, Christopher, Mackiewicz, Andrzej, Rutkowski, Piotr, Guminski, Alexander, Goodman, Grant R, Simmons, Brian, Ye, Chenglin, Yan, Yibing, Schadendorf, Dirk

“…Systemic adjuvant treatment might mitigate the high risk of disease recurrence in patients with resected stage IIC-III melanoma. The BRIM8 study evaluated…”
Get full text

KLINIČKE UPUTE ZA DIJAGNOZU, LIJEČENJE I PRAĆENJE BOLESNIKA OBOLJELIH OD KOLOREKTALNOG RAKA by Vrdoljak, Eduard, Pleština, Stjepko, Dobrila Dintinjana, Renata, Tomaš, Ilijan, Šobat, Hrvoje, Šeparović, Robert, Bolanča, Ante, Vojnovič, Željko, Boban, Marijo, Družijanić, Nikica, Kovač, Dražen, Cambj Sapunar, Liana, Miletić, Damir

“…Rak kolorektuma treći je najčešći maligni tumor muškaraca i četvrti najčešći maligni tumor žena u Republici Hrvatskoj. Klinički se najčešće očituje poremećajem…”
Get full text

CLINICAL GUIDELINES FOR DIAGNOSIS, TREATMENT AND MONITORING OF PATIENTS WITH INVASIVE BREAST CANCER--CROATIAN ONCOLOGY SOCIETY by Šeparović, Robert, Ban, Marija, Silovska, Tajana, Oresković, Lidija Beketić, Soldić, Željko, Podolski, Paula, Pleština, Stjepko, Gugić, Damir, Petković, Marija, Jakić-Razumović, Jasminka, Vojnović, Zeljko, Miše, Branka Petrić, Tomić, Snježana, Stanec, Zdenko, Vrdoljak, Danko Velemir, Drinković, Ivan, Brkljačić, Boris, Mustać, Elvira, Utrobičić, Ivan, Vrdoljak, Eduard

“…Breast cancer is the most common cancer in women. It can be diagnosed in early stage through screening, early detection and educational programs, and when…”
Get full text

Clinical guidelines for diagnosing, treatment and monitoring patients with prostate cancer--Croatian Oncology Society and Croatian Urology Society, Croatian Medical Association by Solarić, Mladen, Grgić, Mislav, Omrcen, Tomislav, Petković, Marija, Fröbe, Ana, Belaj, Nenad, Zorica, Robert, Kruslin, Bozo, Dordević, Gordana, Kastelan, Zeljko, Ruzić, Boris, Gilja, Ivan, Krolo, Ivan, Vilović, Katarina, Librenjak, Davor, Vrdoljak, Eduard, Situm, Marijan, Padovan, Ranka Stern, Vojnović, Zeljko

“…Prostate adenocarcinoma is the second most common solid neoplasm in male population in Croatia. It rarely causes symptoms unless it is advanced. The finding of…”
Get full text

Clinical recommendations for diagnosis, treatment and monitoring of patients with colorectal cancer by Vrdoljak, Eduard, Plestina, Stjepko, Dintinjana, Renata Dobrila, Tomas, Ilijan, Sobat, Hrvoje, Separović, Robert, Bolanca, Ante, Vojnovic, Zeljko, Boban, Marijo, Druzijanić, Nikica, Kovac, Drazen, Sapunar, Liana Cambj, Miletić, Damir

“…Colorectal cancer is the third most common malignant tumour in males and the fourth most common malignancy in women in the Republic of Croatia. It is usually…”
Get full text

Clinical recommendations for diagnosing, treatment and monitoring of patients with ovarian cancer -- Croatian Oncology Society and Croatian Society for Gynecology and Obstetrics as Croatian Medical Association units and Croatian Society of Gynecological Oncology by Matković, Visnja, Haller, Herman, Vrdoljak, Eduard, Corusić, Ante, Jelavić, Tihana Boraska, Strinić, Tomislav, Karnjus-Begonja, Ruzica, Barisic, Dubravko, Tomić, Snjezana, Kukura, Vlastimir, Ban, Marija, Ranka, Stern Padovan, Matic, Mate, Skalec, Suzana Lide, Topolovec, Zlatko, Mrcela, Milanka, Zekan, Josko, Fröbe, Ana, Hajredini, Adem, Babic, Damir, Mamula, Ozren, Brncić-Fischer, Alemka, Vojnović, Zeljko, Sundov, Dinka

“…Ovarian cancer together with fallopian tube represents the fifth most common female cancer in the Republic of Croatia. Epithelial ovarian cancer, serous…”
Get full text

Clinical recommendations for diagnosis, treatment and monitoring of patients with invasive breast cancer by Tomek, Rudolf, Oresković, Lidija Beketić, Vrdoljak, Eduard, Soldić, Zeljko, Podolski, Paula, Plestina, Stjepko, Gugić, Damir, Vojnović, Zeljko, Mise, Branka Petric, Tomić, Snjezana, Fajdić, Josip, Vrdoljak, Danko Velimir, Drinković, Ivan, Brkljacić, Boris, Mustać, Elvira

“…Breast cancer is the most common malignancy in women. Preventive measures, early diagnosis and development of all treatment modalities (surgery, radiotherapy,…”
Get full text

PRAĆENJE ONKOLOŠKIH BOLESNIKA – KLINIČKE PREPORUKE HRVATSKOG DRUŠTVA ZA INTERNISTIČKU ONKOLOGIJU HLZ-a II. dio: rak bubrega, rak mokraćnog mjehura, rak prostate, rak testisa by Gnjidić, Milena, Vojnović, Željko, Čonkaš, Mislav, Grubišić Čabo, Filip, Belev, Borislav, Budisavljević, Anuška, Gilja, Ivan, Dedić Plavetić, Natalija, Šeparović, Robert

“…Liječenje onkoloških bolesnika mora se temeljiti na multidisciplinarnom pristupu, a provodi se u specijaliziranim onkološkim centrima. Nakon završetka…”
Get full text